ES2185805T3 - Medicamentos estabilizadores que contienen hormona tiroidea. - Google Patents

Medicamentos estabilizadores que contienen hormona tiroidea.

Info

Publication number
ES2185805T3
ES2185805T3 ES96933433T ES96933433T ES2185805T3 ES 2185805 T3 ES2185805 T3 ES 2185805T3 ES 96933433 T ES96933433 T ES 96933433T ES 96933433 T ES96933433 T ES 96933433T ES 2185805 T3 ES2185805 T3 ES 2185805T3
Authority
ES
Spain
Prior art keywords
thyroid hormone
pct
stabilizing
medicines containing
containing thyroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96933433T
Other languages
English (en)
Inventor
Wolfgang Lahr
Andrea Friese
Guido Weickgenannt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Synthelabo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo GmbH filed Critical Sanofi Synthelabo GmbH
Application granted granted Critical
Publication of ES2185805T3 publication Critical patent/ES2185805T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION TRATA DE PREPARACIONES FARMACEUTICAS ESTABILIZADAS QUE CONTIENEN HORMONAS TIROIDEAS CUYO COMPONENTE DE ESTABILIZACION ES TIOSULFATO SODICO EN UNA RELACION DE MASA DE HORMONA TIROIDEA Y TIOSULFATO SODICO DE 1:0,1 A 1:50. LA INVENCION TRATA ASIMISMO DE UN PROCEDIMIENTO PARA SU PRODUCION.
ES96933433T 1995-10-27 1996-09-30 Medicamentos estabilizadores que contienen hormona tiroidea. Expired - Lifetime ES2185805T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19541128A DE19541128C2 (de) 1995-10-27 1995-10-27 Stabilisierte schilddrüsenhormonhaltige Arzneimittel

Publications (1)

Publication Number Publication Date
ES2185805T3 true ES2185805T3 (es) 2003-05-01

Family

ID=7776612

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96933433T Expired - Lifetime ES2185805T3 (es) 1995-10-27 1996-09-30 Medicamentos estabilizadores que contienen hormona tiroidea.

Country Status (8)

Country Link
US (1) US5958979A (es)
EP (1) EP0857064B1 (es)
JP (1) JPH11514629A (es)
AT (1) ATE228360T1 (es)
AU (1) AU7217096A (es)
DE (2) DE19541128C2 (es)
ES (1) ES2185805T3 (es)
WO (1) WO1997016178A1 (es)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821625C1 (de) 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
DE19830246A1 (de) * 1998-07-07 2000-01-13 Merck Patent Gmbh Pharmazeutische Zubereitung
US8088060B2 (en) 2000-03-15 2012-01-03 Orbusneich Medical, Inc. Progenitor endothelial cell capturing with a drug eluting implantable medical device
US9522217B2 (en) 2000-03-15 2016-12-20 Orbusneich Medical, Inc. Medical device with coating for capturing genetically-altered cells and methods for using same
US6979462B1 (en) * 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6855333B1 (en) * 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
US6555581B1 (en) 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
KR20040100835A (ko) * 2001-02-15 2004-12-02 킹 파머슈티칼스 리서치 앤드 디벨로프먼트 아이엔씨 안정된 제약및 갑상선 내분비 호르몬 구성물 및 그제조방법
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
US20030198671A1 (en) * 2001-08-10 2003-10-23 Franz G. Andrew Levothyroxine compositions having unique plasma AUC properties
US20030199585A1 (en) * 2001-08-10 2003-10-23 Franz G Andrew Levothyroxine compositions and methods
US20030194436A1 (en) * 2001-08-10 2003-10-16 Franz Andrew G. Immediate release pharmaceutical compositions
US7101569B2 (en) * 2001-08-14 2006-09-05 Franz G Andrew Methods of administering levothyroxine pharmaceutical compositions
US20040152783A1 (en) * 2002-11-05 2004-08-05 Olon Lawrence Peter Controlled absorption of admixed thyroid hormone formulations
ITMI20110713A1 (it) 2011-04-29 2012-10-30 Bracco Imaging Spa Processo per la preparazione di un derivato solfatato di3,5-diiodo-o-[3-iodofenil]-l-tirosina
ITMI20022394A1 (it) 2002-11-13 2004-05-14 Bracco Spa Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
EP1622587B1 (de) * 2003-05-02 2010-04-28 Globopharm Pharmazeutische Produktions- und Handelsgesellschaft m.b.H. Feste pharmazeutische zubereitung enthaltend levothyroxin- und/oder liothyroninsalze
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
GB0316206D0 (en) * 2003-07-10 2003-08-13 Glaxo Group Ltd Pharmaceutical formulation
EP2885005B1 (en) * 2012-08-20 2017-09-27 Merck Patent GmbH Solid pharmaceutical preparation containing levothyroxine
EP2932963A1 (en) 2014-04-16 2015-10-21 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stable pharmaceutical dosage forms comprising Levothyroxine sodium
US9682045B2 (en) 2014-11-21 2017-06-20 Cadila Healthcare Limited Stable pharmaceutical compositions of thyroid hormone drug
PL3576795T3 (pl) * 2017-02-03 2021-10-25 Berlin-Chemie Ag Doustny tarczycowy środek leczniczy
DE102017122807B4 (de) * 2017-09-29 2023-02-09 Berlin-Chemie Ag Orales Schilddrüsentherapeutikum
IT201800003615A1 (it) 2018-03-15 2019-09-15 Altergon Sa Formulazioni altamente stabili di ormone tiroideo in capsule molli
US10231931B1 (en) 2018-03-23 2019-03-19 Genus Lifesciences Inc. Thyroid hormone oral dosage forms and methods of using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546474A1 (de) * 1975-10-17 1977-04-21 Murray M D Israel Injizierbares pharmazeutisches thyroxinpraeparat und verfahren zu dessen herstellung
US4154820A (en) * 1976-02-23 1979-05-15 Akzona Incorporated Compositions containing alkali metal sulfate salts of conjugated estrogens and antioxidants as stabilizers
CN1011118B (zh) * 1986-06-13 1991-01-09 天津医学院附属医院 治疗白内障的眼药水的制药方法
DE4026600A1 (de) * 1990-08-23 1992-02-27 Henning Berlin Gmbh Mittel zur tsh-suppression und behandlung von struma
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
JP2622653B2 (ja) * 1992-12-18 1997-06-18 三洋化成工業株式会社 甲状腺ホルモン水溶液

Also Published As

Publication number Publication date
AU7217096A (en) 1997-05-22
US5958979A (en) 1999-09-28
DE59609926D1 (de) 2003-01-09
JPH11514629A (ja) 1999-12-14
ATE228360T1 (de) 2002-12-15
DE19541128C2 (de) 1997-11-27
WO1997016178A1 (de) 1997-05-09
EP0857064A1 (de) 1998-08-12
DE19541128A1 (de) 1997-04-30
EP0857064B1 (de) 2002-11-27

Similar Documents

Publication Publication Date Title
ES2185805T3 (es) Medicamentos estabilizadores que contienen hormona tiroidea.
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
TW334418B (en) Stilbene derivatives and pharmaceutical compositions
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
DK0706380T3 (da) Indkapslet farmaceutisk præparat
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
DK0701449T3 (da) Fremgangsmåde til fremstilling af en oral fast dosisform indeholdende diclofenac
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
DK0557389T3 (da) Fremgangsmåde til fremstilling af tabletter indeholdende cephalosporansyrederivater ved direkte komprimering
DE59504270D1 (de) Retardtablette mit einem gehalt an diclofenac-na
GR81635B (es)
DE69606777T2 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
DK0825859T3 (da) Anvendelse af forskolin eller ekstrakter indeholdende dette til fremstilling af et lægemiddel til behandling af alkoholafhængighed
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
NZ311681A (en) Process for producing active substances from unused or discarded devices for the transdermal administration of active substances and/or from their production waste
DK0624365T3 (da) Farmaceutisk form til rectal administrering af farmakologisk aktive forbindelser
ES8704488A1 (es) Procedimiento para preparar derivados de 3,4-diazol
GR3021604T3 (en) Application of riluzole as a radiorestorer.
MX9301546A (es) Preparado farmaceutico que contiene un canal activador de potasio y un receptor antagonista de la angiotensina ii y proceso para la fabricacion de tal preparado
NO950187L (no) Ventilerings- og utmatningskapsel for beholder